Tag: Quotient Sciences
CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials
US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development of its COVID-19 drug candidate GP1681 into ... Read More
Quotient Sciences opens formulation, manufacturing facility in US near Philadelphia
Quotient Sciences, a UK-based drug development services provider, has expanded its operations in the US by opening an early phase formulation and manufacturing plant in ... Read More